Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 7/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18327147 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL9234695 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL5839131 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL9234691 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL10770166 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL5839128 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL30958398 | 1.00 | ALDH1A1 (0.76) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL18327149 | 0.94 | ALDH1A1 (0.68) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL899230 | 0.94 | ALDH1A1 (0.68) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 | |
| SCHEMBL899229 | 0.94 | ALDH1A1 (0.68) | ALDH1A1EPHX1ENPP2LPAR2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025010290-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS, INC. (US) | 2025-01-09 | — | — | WO | disclosed |
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20230338577-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-10-26 | — | — | US | disclosed |
| US-11679165-B2 | Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-20 | — | — | US | disclosed |
| US-20160367686-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2016-12-22 | — | — | US | disclosed |
| WO-2016205691-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES AND THEIR USE IN COMPOSITIONS FOR DELIVERING AN AGENT TO A SUBJECT OR CELL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-12-22 | — | — | WO | disclosed |
| US-20160367686-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | ALDH1A1 2146/4885EPHX1 3063/4885ENPP2 1004/4885 |
| US-11679165-B2 | Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof | UGT1A10, AKR1B10, CCR10 | ALDH1A1 12/4885EPHX1 998/4885ENPP2 648/4885 |
| US-20160367686-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | UGT1A10, AKR1B10, CCR10 | ALDH1A1 12/4885EPHX1 998/4885ENPP2 648/4885 |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | LIPC, LIPA, NPC1L1 | ALDH1A1 2430/4885EPHX1 2909/4885ENPP2 1439/4885 |
| US-20230338577-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | UGT1A10, AKR1B10, CCR10 | ALDH1A1 12/4885EPHX1 998/4885ENPP2 648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.